Ugur Sahin sold $4.7M of BioNTech SE (BNTX)

Executed Sep 15, disclosed Sep 16, 1 day later.

Value, as filed

$4.7M

49,000 sh across 2 lots

Executed

Sep 15

the trade date, as filed

Disclosed

Sep 16

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

US Ugur Sahin Chief Executive Officer profile →

Ugur Sahin (Chief Executive Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in BioNTech SE (BNTX). The largest single filing was $8.4M of BNTX (86,000 sh across 2 lots, as filed), executed Sep 11.

The name

BNTX BioNTech SE BNTX · Healthcare · 9 filings in 24 months ticker →

Healthcare · BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ugur Sahin in BNTX

BNTXSALE BioNTech SE $6.2M
64,000 sh across 2 lots
Exec Sep 17
Filed Sep 18 · 4:41 PM ET BNTXSALE BioNTech SE $8.4M
86,000 sh across 2 lots
Exec Sep 11
Filed Sep 14 · 4:50 PM ET BNTXSALE BioNTech SE $2.0M
20,500 sh × $96.31
Exec Sep 10
Filed Sep 11 · 5:18 PM ET BNTXSALE BioNTech SE $7.2M
73,000 sh across 2 lots
Exec Sep 8
Filed Sep 9 · 5:29 PM ET BNTXSALE BioNTech SE $7.9M
76,500 sh across 2 lots
Exec Sep 3
Filed Sep 8 · 4:10 PM ET